CAUTI Prevention Urology Products Market Size, Share and Growth Outlook, 2026

CAUTI Prevention Urology Products Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global CAUTI Prevention Urology Products Market size is forecast to increase from $4.09 Billion in 2026 to $7.4 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

The CAUTI Prevention Urology Products market report provides detailed analysis and outlook of CAUTI Prevention Urology Products segments including By Product Type (Antimicrobial & Coated Catheters, Closed Urinary Drainage Systems, External Catheters, Intermittent, Catheter Securement & Stabilization Devices, Bladder Scanners ), By Application (Urinary Incontinence Management, Acute Surgical & Perioperative Care, Benign Prostatic Hyperplasia, Neurogenic Bladder & Spinal Cord Injury ), By End-User (Hospitals, Long-Term Care Facilities, Home Healthcare Settings, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

CAUTI Prevention Urology Products Industry Overview

Infection Prevention Strategies Driving Innovation in Urology Products

The CAUTI prevention urology products industry is experiencing significant advancement as healthcare systems intensify efforts to reduce catheter-associated urinary tract infections, one of the most common healthcare-associated infections worldwide. Hospitals, long-term care facilities, and outpatient healthcare providers are increasingly adopting infection-control technologies that focus on preventing bacterial colonization, minimizing catheter exposure, and maintaining sterile urinary drainage pathways. Product innovation is increasingly centered on antimicrobial materials, closed-system drainage architectures, and diagnostic tools designed to reduce unnecessary catheterization and improve patient safety outcomes.

Advanced Catheter Materials Enhancing Resistance to Bacterial Biofilm Formation

Biomaterial innovation remains a major area of development within the CAUTI prevention market. A recent peer-reviewed study demonstrated the successful engineering of a hydrogel-coated silicone urinary catheter specifically designed to address two major contributors to catheter-related infections. The specialized coating functions as a low-friction lubricating surface while simultaneously serving as an active antimicrobial barrier. This dual-function architecture significantly delays bacterial biofilm formation, one of the primary mechanisms responsible for catheter-associated urinary tract infections. By reducing microbial adhesion and enhancing catheter insertion performance, hydrogel-coated silicone catheters represent an important advancement in long-term urinary catheter management and infection prevention.

Closed Urinary Drainage Systems Becoming the Clinical Standard

Healthcare institutions are increasingly implementing standardized infection-control protocols focused on maintaining sterile urinary drainage environments. Updated nursing and infection-prevention frameworks across major hospital networks have formalized the transition away from traditional open-interface urine collection systems. Modern CAUTI prevention programs now emphasize the use of pre-packaged aseptic catheterization trays equipped with integrated anti-reflux mechanisms and needleless urine sampling ports. These closed drainage architectures are specifically designed to reduce opportunities for bacterial contamination while maintaining uninterrupted urinary drainage. The widespread adoption of these systems reflects the industry's growing emphasis on reducing healthcare-associated infection rates through standardized device design and procedural controls.

Bladder Scanning Protocols Reducing Unnecessary Catheter Utilization

A growing trend within the CAUTI prevention urology products industry is the integration of diagnostic technologies that help avoid unnecessary catheter placement. Acute care facilities are increasingly requiring the use of portable ultrasound bladder scanners before insertion of Foley catheters or other invasive urinary drainage devices. These screening protocols enable clinicians to objectively confirm urinary retention before proceeding with catheterization. By ensuring that catheter placement occurs only when clinically necessary, hospitals are reducing overall catheter utilization rates, shortening catheter dwell times, and minimizing patient exposure to catheter-associated urinary tract infection risks. The incorporation of noninvasive bladder assessment technologies into routine clinical workflows is becoming a key component of comprehensive CAUTI prevention programs.

CAUTI Prevention Urology Products Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global CAUTI Prevention Urology Products market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company (BD), B. Braun SE, Coloplast A/S, Teleflex Incorporated, ConvaTec Group PLC, Boston Scientific Corporation, Hollister Incorporated, Cardinal Health, Inc., Medline Industries, LP, Cook Medical Incorporated. The CAUTI Prevention Urology Products market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the CAUTI Prevention Urology Products industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth CAUTI Prevention Urology Products Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by CAUTI Prevention Urology Products companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional CAUTI Prevention Urology Products markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

CAUTI Prevention Urology Products Market Competitive Benchmarking and Company Analysis

Leading companies in CAUTI Prevention Urology Products industry include- Becton, Dickinson and Company (BD), B. Braun SE, Coloplast A/S, Teleflex Incorporated, ConvaTec Group PLC, Boston Scientific Corporation, Hollister Incorporated, Cardinal Health, Inc., Medline Industries, LP, Cook Medical Incorporated. The CAUTI Prevention Urology Products market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US CAUTI Prevention Urology Products Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the CAUTI Prevention Urology Products market remains one of the strongest-performing segments in the country.
The US CAUTI Prevention Urology Products Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US CAUTI Prevention Urology Products market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across CAUTI Prevention Urology Products industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian CAUTI Prevention Urology Products markets

Canada's strong CAUTI Prevention Urology Products sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian CAUTI Prevention Urology Products market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany CAUTI Prevention Urology Products Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest CAUTI Prevention Urology Products market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of CAUTI Prevention Urology Products population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany CAUTI Prevention Urology Products industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the CAUTI Prevention Urology Products market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support CAUTI Prevention Urology Products sales through 2034

France CAUTI Prevention Urology Products companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK CAUTI Prevention Urology Products Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of CAUTI Prevention Urology Products distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China CAUTI Prevention Urology Products Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China CAUTI Prevention Urology Products market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of CAUTI Prevention Urology Products industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese CAUTI Prevention Urology Products industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India CAUTI Prevention Urology Products Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian CAUTI Prevention Urology Products market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil CAUTI Prevention Urology Products market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa CAUTI Prevention Urology Products Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

CAUTI Prevention Urology Products Market Segmentation

By Product Type
Antimicrobial & Coated Catheters
Closed Urinary Drainage Systems
External Catheters
Intermittent
Catheter Securement & Stabilization Devices
Bladder Scanners
By Application
Urinary Incontinence Management
Acute Surgical & Perioperative Care
Benign Prostatic Hyperplasia
Neurogenic Bladder & Spinal Cord Injury
By End-User
Hospitals
Long-Term Care Facilities
Home Healthcare Settings
Ambulatory Surgical Centers

Top Companies in CAUTI Prevention Urology Products Industry

Becton, Dickinson and Company (BD)
B. Braun SE
Coloplast A/S
Teleflex Incorporated
ConvaTec Group PLC
Boston Scientific Corporation
Hollister Incorporated
Cardinal Health, Inc.
Medline Industries, LP
Cook Medical Incorporated

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025